1. Application of Reverse Vaccinology and Immunoinformatics to Design a Multitope Vaccine against Gastrointestinal Cancer-inducing <italic>Cryptosporidium Parvum</italic>.
- Author
-
Soltan, Mohamed A., Abdulsahib, Waleed K., Eid, Refaat A., Alshaya, Dalal Sulaiman, Sideeg, Abulqasim M., Osman, Rihab, Alarabi, Tarig Gasim M., Mohamed, Gamal, Al-Salmi, Fawziah A., Fayad, Eman, Abduljabbar, Maram H., Alshehri, Mohammed A., Gouda, Ahmed M., and Eldeen, Muhammad Alaa
- Abstract
Cryptosporidium parvum
(C. parvum) is an apicomplexan protozoan known as a frequent cause of diarrhea. Because of its severe outbreaks and the association with different types of gastrointestinal cancers, it became an urgent need to develop effective solutions against that parasite. In the current study, the complete proteome ofC. parvum was analyzed, and after applying several filtration steps, two proteins, namely Glycoprotein 60 (gp40/15) and thrombospondin-related adhesive protein (TRAP C-1), were selected as the protein candidates for epitope prediction. Next, CTL, HTL and BCL epitopes of each protein candidate were defined, and the best epitopes of each category were assembled alongside suitable linkers and adjuvants to initiate a potential multitope vaccine construct finally. That construct was evaluated for several properties, including its antigenicity, allergenicity, stability, secondary and tertiary structure, and the ability of that 3D predicted model to bind to TLR4. Furthermore, the stability of the constructed vaccine ligand in the TLR4 receptor was deeply investigated through a molecular dynamics simulation. The current study describes the stages of the multitope construct design. It demonstrates the results of that construct computational evaluation where the generated scores support the nomination of that potential vaccine as a solution forC. parvum infection, and further wet lab experiments are required to validate our current findings. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF